Dehradun Call Girls Service 08854095900 Real Russian Girls Looking Models
Â
Abdominal Tuberculosis
1. ABDOMINAL TUBERCULOSIS
P R E S E N T E D B Y: N AVA N E E TA K U S U M
M . S C . N U R S I N G
( 2 N D Y E A R )
C O L L E G E O F N U R S I N G
2. Introduction:
World TB day- 24th March 1882
TB declared as notifiable disease by Indian Government on
May, 9th 2012.
3. TUBERCULOSIS
ďśMajor health problem
ďś7-10 million new cases annually
ďś6% of deaths world wide
ďśAbdominal tuberculosis is a common extrapulmonary
manifestation of tuberculosis.
ďśnon HIV patients 10 â 15 % have extrapulmonary manifestations of
tuberculosis .
ďśHIV infected patients > 50% have extra pulmonarymanifestations of
TB
4. Epidemiology
ďś Global burden of TB is nearly 12 million.
ďś A/C WHO (2013) 8.6 million annual incidence of TB globally and 1.3
million people died from disease in 2012.
ďś India has the worldâs largest TB cases is around 26% of the world TB
cases, followed by China and South Africa.
ďś An estimated 0.45 million new cases of MDR TB worldwide in 2012. >
half in India.
5. ďśIn India, around 3 â 20 % of all cases of bowel obstruction are due
to ATB.
ďśTuberculosis accounts for 5 â 9 % of all small intestinal perforations
in India, second commonest cause after typhoid fever.
ďśATB is an important cause of Malabsorption syndrome in India.
6. 4
⢠Epidemiology:
â Both gender: equally affected
â 35-45 years
⢠Riskfactors:
â Alcoholic liver disease
â HIV infection
⢠9% of all new TB cases are related to HIV
â Advanced age
â Low socioeconomic status
7. Etiology
ďąMycobacterium tuberculosis
Pathogen for most cases of abdominal tuberculosis
ďąMycobacterium bovis
Cause in small percentage of cases, in developing Transmitted by
unpasteurized dairy products.
ďąMycobacterium Avium more likely in HIV infected
patients
10. Mode ofinfection
Swallowing of
infected sputum
Hematogenous spread
from pulmonary focus
Ingestion of contaminated
milk products
Direct spread from
adjacent organs
Pathogenesis of Abdominal TB
13. Order of Frequency ITB:
Ileum > caecum > ascending colon > jejunum
>appendix > sigmoid > rectum > duodenum
> stomach > oesophagus
⢠More than one site may be involved
15. ⢠Most common site of abdominal tuberculosis due to:
âStasis
âAbundant payerâs patches
âAlkaline media
âBacterial contact time is more
âMinimal digestive activity
âMaximum absorption in the area
Ileocaecal Tuberculosis
16. A. Ulcerative type (60%)
â Secondary to pulmonary tuberculosis
â Old malnutritioned people
â Virulent organism
â Poor body resistance
â Commonly in ileum
â Rarely in caecum
Ileocaecal Tuberculosis
17. â Intestinal nodes involvement with caseation and
abscess
â May present with blood in stools, diarrhoea, loss of
appetite and reduced weight
â Complications:
⢠Acute: Ulcer perforation
⢠Chronic: Stricture ď Subacute obstruction
Ileocaecal Tuberculosis
18. B. Hyperplastic Type -10%
⢠Primary GIT tuberculosis
⢠Less virulent organism
⢠Chronic granulomatous lesions in ileoceacal region
⢠Fibroblastic activity in submucosa and subserosa causes
thickening of bowel wall with lymph node enlargement
⢠Presenting as Mass in Right Iliac Fossa (Nodular fixed and firm
mass)
Ileocaecal Tuberculosis
20. 20
ďą 30% of patients
ďą Inflammatory mass with thickened and
ulcerated mucosa
ďą Commonly in ileocaecal region
ďą Cone shaped deformity of caecum
ďą Shortening of ascending colon
C. Ulcerohypertrophic type-30%
21. ⢠It is usually stricture type
⢠May be multiple
⢠Presents with intestinal obstruction
⢠Bowel adhesions, localization, fibrosis, secondary infection are
common
⢠Perforation (5%)
⢠Plain Xray â Multiple air fluid levels
2. Ileal Tuberculosis
23. ⢠It is post primary
⢠Becoming more common
⢠Blood spread
⢠Can develop from diseased mesenteric lymph
nodes, intestines or fallopian tubes
Peritoneal Tuberculosis
24. ⢠Abdominal Cocoon Syndrome
â Dense adhesions in peritoneum and omentum with contents inside
as small bowel causing intestinal obstruction
Peritoneal Tuberculosis
25. A. Acute type âmimics acute abdomen
â Rare
â Features of peritonitis
â Due to perforation or rupture of mesenteric lymph nodes
â Exploratory laparotomy reveals straw coloured fluid with tubercles
in the peritoneum, greater omentum and bowel wall
â Fluid evacuated and sent for culture and AFB study
â Biopsy taken from omentum
Peritoneal Tuberculosis
26. B. Chronic
⢠Abdominal pain
⢠Fever
⢠Ascites
⢠Loss of appetite and weight
⢠Abdominal mass
â Types
a) Ascitic form
b) Encysted form
c) Plastic form
d) Purulent form
Peritoneal Tuberculosis
27. â Common in children and young adults
â abdominal distension
â May cause congenital hydrdocele, umbilical hernia, shifting
dullness, fluid thrill and mass per abdomen
â Rolled up omentum and nodular due to extensive
fibrosis
Ascitic peritoneal tuberculosis:
28. 89
Ascitic Fluid Analysis
-exudate with protein level >3gm/dl
-SAAG <1.1
-lymphocyte predominant cells with cell count as
high as 4000 / mm3
-AFB +ve seen only < 3%
-specific gravity > 1.016
-glucose < 30mg
-LDH > 90 units/lit
-
29. â Ascites gets loculated due to fibrinous deposition
â Dullness is the typical feature
â May present as intra-abdominal mass mimicing ovarian cyst,
mesenteric cyst
â USG guided aspiration and antitubercular drugs to be given
Encysted (Loculated) peritoneal tuberculosis
30. â Widespread adhesions b/w coils of intestine (matted intestines),
abdominal wall, omentum
â Obstruction ď Distension of abdomen
â Colicky abdominal pain (recurrent)
â Diarrhoea, loss of weight, Doughy abdomen
â Open/ laproscopic biopsy (to rule out peritoneal carcinomatosis)
â Anti-tubercular drugs
â Surgery to relieve obstruction by adhesolysis
Plastic Peritoneal Tuberculosis
31. â Direct spread from tuberculous salpingitis
â Mass per abdomen containing pus, omentum, fallopian
tubes, small and large bowel
â May cause umbilical discharge
â Genitourinary tuberculosis usually present
â Anti-tubercular drugs with exporation of umbilical
fistula
Purulent peritoneal tuberculosis
32. 3. Nodal/ Glandular tuberculosis
A. Calcified lesion
B. Acute Mesenteric lymphadenitis
C. Pseudo-mesenteric cyst
D. Tabes mesenterica
E. Chronic Lymphadenitis
⢠Complications
â Abscess formation
33. â Along the line of the mesentery a single or multiple
calcified lesions
â Payerâs patches involved
â No active infection
â May be on right or left side (R>L)
â Antitubercular drugs
Calcified lesion:
34. â Common in children
â Mimics acute appendicitis
â Tender mass of lymph node palpable in Right iliac
fossa which is non-mobile
â Intestines adherant to caseating lymph nodes
ď obstruction
â Surgery for appendicitis or obstruction with lymph
node biopsy
â Antitubercular drugs
Acute Mesenteric Lymphadenits
35. â Mimicking a mesenteric cyst
3. Tabes mesenterica
â Massive enlargement of mesenteric lymph
nodes due to tuberculosis
4. Chronic Lymphadenitis
â Children
â Failure to thrive
â Lymph node on deep palpation in right iliac fossa
PSEUDO-MESENTERIC CYST
40. ⢠It can occur due to disseminated or miliary form of the disease
⢠Most commonly encountered in HIV pt(developed countries)
⢠Fever, weight loss, diarrhea, left upper abdominal pain,
splenomegaly
⢠-Percutaneous needle biopsy is the gold standard for diagnosis.
⢠- CECT-abdomen-multiple hypo echoic foci(<2cm)
SPLEENIC TUBERCULOSIS
41. Gross pathology of resected spleen showing innumerable caseating granulomas consistent with splenic tuberculosis.
Mackowiak P A et al. Clin Infect Dis.2011;52:418-420
The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights
reserved. For Permissions, please e-mail: journals.permissions@oup.com.
42. Computed tomograph scan of the abdomen showing a spleen diffusely infiltrated by small, hypodense lesions
consistent with splenic granulomas.
Mackowiak P A et al. Clin Infect Dis.2011;52:418-420
The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights
reserved. For Permissions, please e-mail: journals.permissions@oup.com.
43. ⢠It is rare
⢠Often associated with miliary TB & immunocompromised pt
⢠Result from lymphohaematogenous dissemimation after pulmonary
exposure
⢠Anorexia,malaise fever,weight loss
⢠Investication: FNAC & BIOPSY
PANCREATIC TB
44. A. Oesophageal (0.2% of abdominal)
B. Gastroduodenal(1%)
C. Retroperitoneal tuberculosis
5. Rare types
45. Esophageal Tuberculosis
⢠Extension from mediastinal lymph nodes or pulmonary.
⢠Ulceration, nodularity, stricture, sinus track formation, and fistulae
⢠Dysphagia, odynophagia, choking, and aspiration due to
tracheoesophageal or bronchoesophageal fistula and upper GI bleeding.
⢠CXR, CT scan, Barium swallow
⢠Upper GI Endoscopy with biopsy is the diagnostic procedure of choice.
48. PATHOPHYSIOLOGY
Lymphatic obstruction of
mesentery and bowel
ďŽ Thick fixed mass
Regional lymph nodes
⢠Hyperplasia
⢠Caseation necrosis
⢠Calcification
Inflammatory process in submucosa penetrates to serosa
Tubercles on serosal surface
Bacilli reach lymphatics
Bacilli via lymphatics
49. ⢠Constitutional symptoms
â fever, night sweats, anorexia, weight loss, failure to thrive(in
children), malaise, anemia, lethargy, lassitude
â Observed in 30% patients
⢠Atypical symptoms
â Lower GI bleed, fistulas, PID like pain, dysphagia
⢠Pain (80%-95%)
â Colicky (luminal stenosis)
â Continous ( LN involvement)
CLINICAL MANIFESTATION
50. ⢠Diarrhoea (11%-20%)
⢠Alternating constipation and diarrhoea
⢠Abdominal mass
â in right iliac fossa (35%)
â Hard, nodular, fixed, nontender
mass mimicing ca caecum
⢠Subacute intestinal obstruction (20%)
26
51. Diagnostic Findings
⢠No specific diagnostic blood tests available
⢠Common blood parameters:
â Elevated ESR
⢠Almost always raised but not exceed 60 mm/hr
â Mild anemia
â Mild leukocytosis
â Raised CRP
â Hypoproteinemia
â Hypoalbuminemia
52. Tuberculin skin test
A +ve tuberculin skin test has been reported in 55 to 100 % pts. with
abdominal tuberculosis. However in areas where TB is highly endemic
, +ve tst neither confirms the diagnosis of abdominal TB nor excludes
it
30
55. CECT
⢠Ascites can be free or loculated because of high protein
and cellular contents of the fluid.
⢠Mesenteric involvement and presence of
ďmacronodules (> 5mm in diameter),
ďa thin omental line
ďperitoneal or extraperitoneal masses
ď splenomegaly or splenic calcification
56. Barium study
⢠Pulled up caecum, conical caecum, pulled down hepatic flexure
â Obtuse ileocaecal angle; straightening (Goose neck)
â Steirlin sign: Hurrying of barium due to rapid flow and lack of barium in inflamed site
â Fleischner sign (Inverted umbrella sign): Narrow ileum with thickened ileocaecal valve
â Mega Ileum: Dilatation of proximal ileum
58. Endoscopy
ďą Colonoscopy is of value to rule out malignancy.
ďą It is easiest and most direct method in establishing the
diagnosis.
ďą Shows mucosal nodules or ulcers , deformed ileo-cecal
valve, mucosal oedema
ďą Biopsy can be taken to confirm diagnosis.
ďą Capsule endoscopy is also useful to see small intestine
pathology in difficult cases .
56
65. 73
Pyrazinamide 500 mg tabs
20-25 mg/kg
PO
Arthralgias, hepatic
toxicity,
hyperuricemia,
gastrointestinal upset
Ethambutol[âĄ] (Myambutol) 100,
400 mg tabs
Streptomycin
1
5-25 mg/kg
PO
15mg/kg IM
Decreased red-green
color discrimination,
decreased visual acuity
Vestibular and auditory
toxicity, renal damage
Drug/formulation Dosage Adverse effect
66. Second-Line Drugs
Capreomycin (Capastat) 15 mg/kg IM (max 1 g) Auditory and vestibular
toxicity, renal damage
Kanamycin (Kantrex and others) 15 mg/kg IM, IV (max 1 g)
Amikacin (Amikin) 15 mg/kg IM, IV (max 1 g)
Auditory toxicity, renal
damage
Auditory toxicity, renal
damage
Cycloserine[Âś] (Seromycin )
Ethionamide (Trecator-SC)
10-15 mg/kg in two doses
(max 500 mg bid) PO
15-20 mg/kg in two doses
(max 500 mg bid) PO
Ciprofloxacin (Cipro and others) 750-1500 mg PO, IV
Psychiatric symptoms,
seizures Gastrointestinal
and hepatic toxicity,
hypothyroidism
Nausea, abdominal pain,
restlessness, confusion
Ofloxacin (Floxin) 600-800 mg PO, IV
Nausea, abdominal pain,
restlessness, confusion75
Drug Dosage Adverse effect
67. 76
Levofloxacin (Levaquin) 500-1000 mg PO, IV Nausea, abdominal pain,
restlessness, confusion
Gatifloxacin[Âś] (Tequin) 400 mg PO, IV
Nausea, abdominal pain,
restlessness, confusion
Moxifloxacin[œœ] (Avelox)
Aminosalicylic acid (PAS; Paser)
400 mg PO, IV
8-12 g in 2-3 doses PO
Nausea, abdominal pain,
restlessness, confusion
Gastrointestinal
disturbance
Drug Dosage Adverse effect
68. Treatment categories according to DOTS strategy:
77
Category of
treatment
Type of patient Regimen
Category I
New sputum smear- positive
2(HRZE)3
4(HR)3
- sputum smear negative
- extra-pulmonary
Category II
- Relapse
- Failure
- Defaulters
2(HRZES)3
1(HRZE)3
5(HRE)3
70. 1. Limited Ileocaecal resection with 5 cm margin
2. Stricturoplasty- single stricture
3. Single strictutre with friable bowel : Resection
4. Multiple Strictures: Resection and anastomosis
5. Multiple strictures with long segment gaps: Multiple
stricturiplasty
Surgical Management:
71. NURSING MANAGEMENT
1. Altered body temperature related to diseases process as evidenced by raised body
temperature .
2. Impaired gas exchange related to an imbalance in ventilation-perfusion ratio as
evidenced by Ascites, tachycardia and laboured breathing.
3. Acute Pain related to disease condition as evidenced by verbal reports of pain in the
abdominal region.
4. Fatigue related to anemia and advanced disease as evidenced by anemia and
physical complaints of tiredness.
5. Imbalanced nutrition less than body requirements related to disease condition as
evidenced by frequent nausea, vomiting and loss of appetite.
72. NURSING DIAGNOSIS
6. Self-care deficit related to surgical procedure secondary to increased work of breathing and
insufficient ventilation and oxygenation.
7. Electrolyte imbalance related to inadequate dietary intake and diarrhoea as evidenced by serum
electrolyte levels.
8. Altered bowel pattern related to low fiber diet and inactivity (as evidenced by infrequent, hard
stools; painful defecation; abdominal distention)
9. Impaired Skin Integrity related to surgical incision, Immobility, poor circulation, chronic disease state
as evidenced by redness.
73. Altered body temperature related to diseases process
as evidenced by raised body temperature
â˘Monitor vital signs
â˘Provide tepid water sponging to axilla, forehead and whole body
â˘Give oral liquid fluid
â˘Administer Antipyretics as per prescription.
â˘Remove unnecessary clothing
â˘Promote a well ventilated area to patient
â˘Promote adequate rest periods.
74. Impaired gas exchange related to an imbalance in ventilation-
perfusion ratio as evidenced by Ascites, tachycardia and
laboured breathing.
Nursing Interventions:
⢠Monitor vital signs
⢠Give Sem ifowler position.
⢠Administer oxygen therapy by nasal catheter 3 L/m.
⢠Continued with pulse oximeter and record patientâs ventilatory parameters.
â˘Reporting any changes.
â˘Assist for abdominal Paracentesis (if required)
75. Acute Pain related to disease condition as evidenced by
verbal reports of pain in the abdominal region
â˘Monitor vital sign (T,P,R, BP)
â˘Assess the level of pain
â˘Determining the clientâs pain area, frequency and threshold.
â˘Perform physical examination to identify abdominal mass, nodules etc.
â˘Administering analgesics according to the prescription.
76. Fatigue related to anemia and advanced disease as evidenced
by anemia and physical complaints of tiredness
Nursing Interventions:
â˘Ensure that the client has adequate periods of rest.
â˘Monitoring sleep pattern.
â˘Guiding to avoid physical exertion.
⢠Administer prescribed BT.
77. Imbalanced nutrition less than body requirements related to
disease condition as evidenced by frequent nausea,
vomiting and loss of appetite.
Nursing Interventions:
â˘Monitor daily intake of prescribed diet and observe dietary acceptance.
â˘Ask for the food preferences.
â˘Prepare a diet plan a/c to that.
â˘Provide small, frequent and tolerating feed.
â˘Watch for occurrences of nausea and vomiting after feeding; medicating with
prescribed antiemetic.
78. References
Sharma R. Abdominal Tuberculosis. Imaging Science Today 2009: 146. Available from:
URL: http://www.imagingsciencetoday.com/node/146
Sood R, Sethu Madhavan M. Diagnostic approach to abdominal tuberculosis. In: Agarwal
AK, Jain DG, editors. Clinical Medicine: A Practical manual for students and
practitioners. India: Jaypee Brothers Medical Publishers (P) Ltd, 2007: 249
World Health Organization. Global tuberculosis report 2013. Geneva: WHO. 23 Oct
2013. Available from: URL: http://apps.who.int/iris/bitstream/10665/91355/1/
9789241564656_eng.pdf